Home Insights When Fuel Runs Low: The Hidden Impact on Medicines and Medical Information Service

When Fuel Runs Low: The Hidden Impact on Medicines and Medical Information Service

The global fuel crisis is often discussed in terms of rising petrol prices and economic pressure, but its impact extends far beyond the pump. One of the less visible yet critical consequences is the strain it places on healthcare systems, particularly the supply and availability of medicines. Modern pharmaceutical supply chains depend heavily on fuel to transport raw materials and finished products across the world, meaning even small disruptions can quickly translate into shortages and delays.

In this environment, access to accurate and timely information becomes just as critical as access to the medicines themselves. As uncertainty around supply increases, healthcare professionals and patients rely heavily on Medical Information (MI) services for guidance on availability, shortages, and appropriate alternatives. MI is no longer just a support function, it becomes a frontline resource, enabling informed decision-making, reducing risk, and maintaining trust.
In times of disruption, the ability of MI to provide clear, reliable, and up-to-date information is essential to ensuring continuity of care in an increasingly complex healthcare landscape.

The Link Between Fuel and Medicine Supply

Modern pharmaceutical supply chains are highly globalised and tightly interconnected. Active pharmaceutical ingredients (APIs) are often manufactured in one region, packed in another, and distributed worldwide. This system depends heavily on:

  • Air freight for high-value and temperature-sensitive medicines
  • Sea freight for bulk pharmaceutical shipments
  • Road transport for last-mile delivery to hospitals, pharmacies, and patients

Fuel disruptions directly impact all three.

Prior to the fuel crisis, Australia already has nearly 400 medicines in shortage. As fuel costs rise and transport routes are disrupted:

  • Deliveries will be delayed
  • Logistics costs increase
  • Supply becomes less predictable

The Rise in Medical Information Demand

As medicine availability becomes less certain, Medical Information (MI) services play a critical role.

When patients and healthcare professionals cannot access prescribed treatments, they turn to MI teams for support. This leads to a surge in inquiries related to:

  • Drug availability and supply status
  • Ongoing or anticipated shortages
  • Suitable therapeutic alternatives
  • Guidance on switching treatments

This shift transforms MI from a reactive support function into a frontline resource during times of crisis.

The Risk of Misinformation and Outdated Content

One of the most significant challenges during supply disruptions is the rapid pace at which information changes.

In a stable environment, medical content such as standard response documents can remain accurate for extended periods. However, during a fuel-driven supply crisis:

  • Availability status can change frequently
  • Alternative treatment guidance evolves quickly

This creates a high-risk environment for:

  • Outdated medical information being shared
  • Inconsistent messaging across different channels
  • Increased reliance on unofficial or unverified sources

Without strong quality controls, there is a real risk that misinformation could influence clinical decisions and/or patient behaviour.

The Role of Medical Information in Crisis Response

Medical Information teams are uniquely positioned to mitigate these risks.

By providing accurate, up-to-date, and scientifically validated information, MI functions help bridge the gap between supply chain disruptions and patient care.

Key responsibilities during this period include:

  • Communicating clearly about drug availability and known shortages
  • Providing evidence-based information to support healthcare professionals in making correct decisions
  • Ensuring alignment with the latest regulatory and safety guidance
  • Rapidly updating internal content to reflect current realities

This requires not only scientific expertise, but also strong coordination with supply chain, regulatory, and pharmacovigilance teams.

Conclusion

The fuel crisis is not just an energy issue; it is a healthcare challenge with far-reaching implications. From medicine shortages to increased demand for reliable information, the impact is both immediate and evolving.

As supply chains come under pressure, Medical Information services become more critical than ever. They serve as a trusted source of truth in an environment where uncertainty, misinformation, and rapid change are the norm.

Ensuring that patients and healthcare professionals have access to accurate, timely, and actionable information is not just a service, it is a responsibility.

In a world where fuel shortages can disrupt the flow of medicines, the role of Medical Information is clear: to keep the flow of knowledge steady, reliable, and grounded in science.

If your organisation is experiencing increased demand for accurate, timely medical information or navigating challenges related to drug shortages and supply disruptions, I can help. With experience in Medical Information services, quality management, and compliance-driven environments, I support teams in delivering reliable, patient-focused information while maintaining high quality standards. Feel free to reach out to discuss how Medical Information services can strengthen your response during periods of uncertainty and ensure continuity of trusted communication.